Skip to main content
Top
Published in: Cancer Causes & Control 10/2016

01-10-2016 | Original paper

The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database

Authors: Anna B. Beckmeyer-Borowko, Caryn E. Peterson, Katherine C. Brewer, Mary A. Otoo, Faith G. Davis, Kent F. Hoskins, Charlotte E. Joslin

Published in: Cancer Causes & Control | Issue 10/2016

Login to get access

Abstract

Purpose

Previous studies assessing racial and ethnic differences in ovarian cancer (OVCA) diagnosis stage fail to present subtype-specific results and provide historic data on cases diagnosed between 10 and 20 years ago. The purpose of this analysis is to assess non-Hispanic Black (NHB) and non-Hispanic White (NHW) differences in late-stage diagnosis including; (1) factors associated with late-stage diagnosis of invasive epithelial OVCA overall and by histologic subtypes, (2) potential changes across time and (3) current patterns of trends in a national cancer registry in the USA and Puerto Rico between 1998 and 2011.

Methods

NHB and NHW OVCA cases were derived from the National Cancer Database (NCDB). Diagnosis stage was analyzed as a dichotomous and a four level-category variable, respectively; early (stages I and II; localized) versus late (stages III and IV; regional and distant) and stages I, II, III and IV. Diagnosis period was trichotomized (1998–2002, 2003–2007, 2008–2011). Racial differences in stage were tested using Chi-square statistics. Odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated using multivariable binomial and generalized ordered logistic regressions. Interactions between race and diagnosis period were evaluated.

Results

Between 1998 and 2011, 11,562 (7.8 %) NHB and 137,106 (92.2 %) NHW were diagnosed with OVCA. In adjusted models, NHB were significantly more likely diagnosed with late-stage OVCA than NHW (ORadj 1.26, 95 % CI 1.19–1.33). Interaction between race and diagnosis period was marginally significant (p value = 0.09), with racial differences in stage decreasing over time (1998–2002: ORadj 1.36, 95 % CI 1.23–1.49; 2003–2007: ORadj 1.27, 95 % CI 1.15–1.39; 2008–2011; ORadj 1.15, 95 % CI 1.05–1.27). NHB were also more likely to be diagnosed with stage 4 high-grade serous (ORadj 1.46, 95 % CI 1.22–1.74), clear cell (ORadj 2.71, 95 % CI 1.94–3.79) and mucinous (ORadj 2.78, 95 % CI 2.24–3.46) carcinomas than NHW.

Conclusions

Racial differences in late-stage OVCA diagnosis exist; however, these differences are decreasing with time. Within NCDB, NHB are significantly more likely diagnosed with late-stage OVCA and more specifically high-grade serous, clear cell and mucinous carcinomas than NHW.
Footnotes
1
ICD-04 epithelial histology codes included: 8010, 8012, 8013, 8015, 8020, 8021, 8022, 8030, 8031, 8032, 8033, 8040, 8041, 8045, 8046, 8050, 8051, 8052, 8070, 8071, 8072,8073, 8074, 8120, 8130, 8140, 8141, 8143, 8144, 8145, 8148, 8170, 8190, 8200, 8201, 8214, 8230, 8231, 8240, 8241, 8243, 8244, 8245, 8246, 8249, 8255, 8260, 8310, 8313, 8323, 8380, 8381, 8382, 8440, 8441, 8442, 8450, 8460, 8461, 8462, 8470, 8471, 8472, 8480, 8481, 8482, 8490, 8562, 8570, 8574, 9000, 9014 and 9015.
 
Literature
1.
3.
go back to reference Moyer VA (2012) Screening for Ovarian Cancer: US preventive services task force reaffirmation recommendation statement. Ann Intern Med 157(12):900–904CrossRefPubMed Moyer VA (2012) Screening for Ovarian Cancer: US preventive services task force reaffirmation recommendation statement. Ann Intern Med 157(12):900–904CrossRefPubMed
4.
go back to reference Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS (2008) Racial disparities in surgical treatment and survival of epithelial ovarian cancer in USA. J Surg Oncol 97(2):103–107CrossRefPubMed Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS (2008) Racial disparities in surgical treatment and survival of epithelial ovarian cancer in USA. J Surg Oncol 97(2):103–107CrossRefPubMed
5.
go back to reference Terplan M, Temkin S, Tergas A, Lengyel E (2008) Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer. Gynecol Oncol 111(2):173–178CrossRefPubMedPubMedCentral Terplan M, Temkin S, Tergas A, Lengyel E (2008) Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer. Gynecol Oncol 111(2):173–178CrossRefPubMedPubMedCentral
6.
go back to reference Alvarez RD, Karlan BY, Strauss JF (2016) Ovarian cancers: evolving paradigms in research and care. Report from the Institute of Medicine, Gynecologic oncology Alvarez RD, Karlan BY, Strauss JF (2016) Ovarian cancers: evolving paradigms in research and care. Report from the Institute of Medicine, Gynecologic oncology
7.
go back to reference Braicu EI, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C (2011) Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer 105(12):1818–1824CrossRefPubMedPubMedCentral Braicu EI, Sehouli J, Richter R, Pietzner K, Denkert C, Fotopoulou C (2011) Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers. Br J Cancer 105(12):1818–1824CrossRefPubMedPubMedCentral
8.
go back to reference Seidman JD, Kurman RJ, Ronnett BM (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27(7):985–993CrossRefPubMed Seidman JD, Kurman RJ, Ronnett BM (2003) Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 27(7):985–993CrossRefPubMed
12.
go back to reference Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY (2008) Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9(3):222–231CrossRefPubMed Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY (2008) Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol 9(3):222–231CrossRefPubMed
13.
go back to reference Morris CR, Sands MT, Smith LH (2010) Ovarian cancer: predictors of early-stage diagnosis. Cancer Causes Control 21(8):1203–1211CrossRefPubMed Morris CR, Sands MT, Smith LH (2010) Ovarian cancer: predictors of early-stage diagnosis. Cancer Causes Control 21(8):1203–1211CrossRefPubMed
14.
go back to reference Barnholtz-Sloan JS, Tainsky MA, Abrams J, Severson RK, Qureshi F, Jacques SM, Levin N, Schwartz AG (2002) Ethnic differences in survival among women with ovarian carcinoma. Cancer 94(6):1886–1893CrossRefPubMed Barnholtz-Sloan JS, Tainsky MA, Abrams J, Severson RK, Qureshi F, Jacques SM, Levin N, Schwartz AG (2002) Ethnic differences in survival among women with ovarian carcinoma. Cancer 94(6):1886–1893CrossRefPubMed
15.
go back to reference Parham GP, Hicks ML (1997) The national cancer data base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 80(4):816–826CrossRefPubMed Parham GP, Hicks ML (1997) The national cancer data base report on malignant epithelial ovarian carcinoma in African-American women. Cancer 80(4):816–826CrossRefPubMed
17.
go back to reference Winchester DP, Stewart AK, Phillips JL, Ward EE (2010) The National Cancer Data Base: past, present, and future. Ann Surg Oncol 17(1):4–7CrossRefPubMed Winchester DP, Stewart AK, Phillips JL, Ward EE (2010) The National Cancer Data Base: past, present, and future. Ann Surg Oncol 17(1):4–7CrossRefPubMed
19.
go back to reference Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG (2012) Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 120(3):612–618CrossRefPubMed Baldwin LA, Huang B, Miller RW, Tucker T, Goodrich ST, Podzielinski I, DeSimone CP, Ueland FR, van Nagell JR, Seamon LG (2012) Ten-year relative survival for epithelial ovarian cancer. Obstet Gynecol 120(3):612–618CrossRefPubMed
20.
go back to reference Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, Mutch DG, Bristow RE (2015) Ovarian cancer in the USA: contemporary patterns of care associated with improved survival. Gynecol Oncol 136(1):11–17CrossRefPubMed Cliby WA, Powell MA, Al-Hammadi N, Chen L, Philip Miller J, Roland PY, Mutch DG, Bristow RE (2015) Ovarian cancer in the USA: contemporary patterns of care associated with improved survival. Gynecol Oncol 136(1):11–17CrossRefPubMed
21.
go back to reference Pollack CE, Bekelman JE, Epstein AJ, Liao K, Wong YN, Armstrong K (2011) Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care 49(11):999–1006PubMedPubMedCentral Pollack CE, Bekelman JE, Epstein AJ, Liao K, Wong YN, Armstrong K (2011) Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care 49(11):999–1006PubMedPubMedCentral
22.
go back to reference Zevallos JP, Mitra N, Swisher-McClure S (2016) Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma. Head Neck 38(3):402–409CrossRefPubMed Zevallos JP, Mitra N, Swisher-McClure S (2016) Patterns of care and perioperative outcomes in transoral endoscopic surgery for oropharyngeal squamous cell carcinoma. Head Neck 38(3):402–409CrossRefPubMed
23.
go back to reference Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM (2000) UNmet health needs of uninsured adults in the united states. JAMA 284(16):2061–2069CrossRefPubMed Ayanian JZ, Weissman JS, Schneider EC, Ginsburg JA, Zaslavsky AM (2000) UNmet health needs of uninsured adults in the united states. JAMA 284(16):2061–2069CrossRefPubMed
24.
go back to reference Ioannou GN, Chapko MK, Dominitz JA (2003) Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98(9):2082–2091CrossRefPubMed Ioannou GN, Chapko MK, Dominitz JA (2003) Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol 98(9):2082–2091CrossRefPubMed
25.
go back to reference Potosky AL, Breen N, Graubard BI, Parsons PE (1998) The Association between Health Care Coverage and the Use of Cancer Screening Tests: results from the 1992 National Health Interview Survey. Med Care 36(3):257–270CrossRefPubMed Potosky AL, Breen N, Graubard BI, Parsons PE (1998) The Association between Health Care Coverage and the Use of Cancer Screening Tests: results from the 1992 National Health Interview Survey. Med Care 36(3):257–270CrossRefPubMed
26.
go back to reference Reid BC, Rozier RG (2006) Continuity of care and early diagnosis of head and neck cancer. Oral Oncol 42(5):510–516CrossRefPubMed Reid BC, Rozier RG (2006) Continuity of care and early diagnosis of head and neck cancer. Oral Oncol 42(5):510–516CrossRefPubMed
27.
go back to reference Kirsner RS, Wilkinson JD, Ma F, Pacheco H, Federman DG (2005) THe association of medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma. Arch Dermatol 141(6):753–757CrossRefPubMed Kirsner RS, Wilkinson JD, Ma F, Pacheco H, Federman DG (2005) THe association of medicare health care delivery systems with stage at diagnosis and survival for patients with melanoma. Arch Dermatol 141(6):753–757CrossRefPubMed
29.
go back to reference Siminoff LA, Graham GC, Gordon NH (2006) Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors. Patient Educ Couns 62(3):355–360CrossRefPubMed Siminoff LA, Graham GC, Gordon NH (2006) Cancer communication patterns and the influence of patient characteristics: disparities in information-giving and affective behaviors. Patient Educ Couns 62(3):355–360CrossRefPubMed
30.
go back to reference Sommers BD, Baicker K, Epstein AM (2012) Mortality and access to care among adults after state medicaid expansions. N Engl J Med 367(11):1025–1034CrossRefPubMed Sommers BD, Baicker K, Epstein AM (2012) Mortality and access to care among adults after state medicaid expansions. N Engl J Med 367(11):1025–1034CrossRefPubMed
31.
go back to reference Sorkin DH, Ngo-Metzger Q, De Alba I (2010) Racial/ethnic discrimination in health care: impact on perceived quality of care. J Gen Intern Med 25(5):390–396CrossRefPubMedPubMedCentral Sorkin DH, Ngo-Metzger Q, De Alba I (2010) Racial/ethnic discrimination in health care: impact on perceived quality of care. J Gen Intern Med 25(5):390–396CrossRefPubMedPubMedCentral
33.
go back to reference Diez-Roux AV, Nieto FJ, Muntaner C, Tyroler HA, Comstock GW, Shahar E, Cooper LS, Watson RL, Szklo M (1997) Neighborhood environments and coronary heart disease: a multilevel analysis. Am J Epidemiol 146(1):48–63CrossRefPubMed Diez-Roux AV, Nieto FJ, Muntaner C, Tyroler HA, Comstock GW, Shahar E, Cooper LS, Watson RL, Szklo M (1997) Neighborhood environments and coronary heart disease: a multilevel analysis. Am J Epidemiol 146(1):48–63CrossRefPubMed
34.
go back to reference Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMed Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson R (2002) Geocoding and monitoring of US socioeconomic inequalities in mortality and cancer incidence: does the choice of area-based measure and geographic level matter?: The Public Health Disparities Geocoding Project. Am J Epidemiol 156(5):471–482CrossRefPubMed
35.
go back to reference Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M (2013) The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5(Suppl 1):3–29CrossRefPubMedPubMedCentral Søgaard M, Thomsen RW, Bossen KS, Sørensen HT, Nørgaard M (2013) The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5(Suppl 1):3–29CrossRefPubMedPubMedCentral
36.
go back to reference Aune G, Torp SH, Syversen U, Hagen B, Tingulstad S (2012) Ten years’ experience with centralized surgery of Ovarian Cancer in One Health Region in Norway. Int J Gynecol Cancer 22(2):226–231CrossRefPubMed Aune G, Torp SH, Syversen U, Hagen B, Tingulstad S (2012) Ten years’ experience with centralized surgery of Ovarian Cancer in One Health Region in Norway. Int J Gynecol Cancer 22(2):226–231CrossRefPubMed
37.
go back to reference Vernooij F, Heintz APM, Coebergh J-W, Massuger LFAG, Witteveen PO, van der Graaf Y (2009) Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 112(3):455–461CrossRefPubMed Vernooij F, Heintz APM, Coebergh J-W, Massuger LFAG, Witteveen PO, van der Graaf Y (2009) Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands. Gynecol Oncol 112(3):455–461CrossRefPubMed
38.
go back to reference Bristow RE, Palis BE, Chi DS, Cliby WA (2010) The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 118(3):262–267CrossRefPubMed Bristow RE, Palis BE, Chi DS, Cliby WA (2010) The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol 118(3):262–267CrossRefPubMed
41.
go back to reference Frey WH (2010) New racial segregation measures for states and large metropolitan areas: analysis of the 2005–2009 American Community Survey. Brookings Institute, Washington, DC Frey WH (2010) New racial segregation measures for states and large metropolitan areas: analysis of the 2005–2009 American Community Survey. Brookings Institute, Washington, DC
Metadata
Title
The effect of time on racial differences in epithelial ovarian cancer (OVCA) diagnosis stage, overall and by histologic subtypes: a study of the National Cancer Database
Authors
Anna B. Beckmeyer-Borowko
Caryn E. Peterson
Katherine C. Brewer
Mary A. Otoo
Faith G. Davis
Kent F. Hoskins
Charlotte E. Joslin
Publication date
01-10-2016
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 10/2016
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-016-0806-6

Other articles of this Issue 10/2016

Cancer Causes & Control 10/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine